Therapeutic Asset Ratings
705 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Anti-Thymoglobulin, Rabbit
N-RAS Gene Amplification
Masonic Cancer Center, University of Minnesota
P2
CCC
(53)
Anti-Thymoglobulin, Rabbit
Peroxisomal Disorders
Masonic Cancer Center, University of Minnesota
P2
CCC
(53)
Anti-Thymoglobulin, Rabbit
PTPN11 Gene Mutation
Masonic Cancer Center, University of Minnesota
P2
CCC
(53)
Anti-Thymoglobulin, Rabbit
Recessive Leukodystrophies
Masonic Cancer Center, University of Minnesota
P2
CCC
(53)
Anti-Thymoglobulin, Rabbit
Severe Osteopetrosis
Masonic Cancer Center, University of Minnesota
P2
CCC
(53)
Anti-Thymoglobulin, Rabbit
Sly Syndrome
Masonic Cancer Center, University of Minnesota
P2
CCC
(53)
Anti-Thymoglobulin, Rabbit
Somatic Mutation
Masonic Cancer Center, University of Minnesota
P2
CCC
(53)
Anti-Thymoglobulin, Rabbit
Sphingolipidoses
Masonic Cancer Center, University of Minnesota
P2
CCC
(53)
Anti-Thymoglobulin, Rabbit
Sphingomyelin Deficiency
Masonic Cancer Center, University of Minnesota
P2
CCC
(53)
Anti-Thymoglobulin, Rabbit
Li-Fraumeni Syndrome
Masonic Cancer Center, University of Minnesota
P2
CCC
(53)
Anti-Thymoglobulin, Rabbit
Zellweger Syndrome
Masonic Cancer Center, University of Minnesota
P2
CCC
(53)
Busulphan
Acyl-CoA Oxidase Deficiency
Masonic Cancer Center, University of Minnesota
P2
CCC
(53)
Busulphan
Adrenoleukodystrophy With Cerebral Involvement
Masonic Cancer Center, University of Minnesota
P2
CCC
(53)
Busulphan
Alpha-methylacyl-CoA Racmase Deficiency
Masonic Cancer Center, University of Minnesota
P2
CCC
(53)
Busulphan
CBL-Related Disorder
Masonic Cancer Center, University of Minnesota
P2
CCC
(53)
Busulphan
Central Nervous System Leukemia
Masonic Cancer Center, University of Minnesota
P2
CCC
(53)
Busulphan
Chromosomal Disorder
Masonic Cancer Center, University of Minnesota
P2
CCC
(53)
Busulphan
D-Bifunctional Enzyme Deficiency
Masonic Cancer Center, University of Minnesota
P2
CCC
(53)
Busulphan
Dyskeratosis Congenita
Masonic Cancer Center, University of Minnesota
P2
CCC
(53)
Busulphan
Hereditary Persistence Of Fetal Hemoglobin
Masonic Cancer Center, University of Minnesota
P2
CCC
(53)
Busulphan
Glycoprotein Metabolic Disorders
Masonic Cancer Center, University of Minnesota
P2
CCC
(53)
Busulphan
Transplant Rejection
Masonic Cancer Center, University of Minnesota
P2
CCC
(53)
Busulphan
Hereditary Leukoencephalopathy With Axonal Spheroids (HDLS; CSF1R Mutation)
Masonic Cancer Center, University of Minnesota
P2
CCC
(53)
Busulphan
Infantile Refsum Disease
Masonic Cancer Center, University of Minnesota
P2
CCC
(53)
Busulphan
B-Lymphoblastic Leukemia/Lymphoma With IAMP21
Masonic Cancer Center, University of Minnesota
P2
CCC
(53)
Showing 201 to 225 of 705 assets
Previous
Page 9 of 29
Next